Wave Life Sciences Ltd. - Ordinary Shares (WVE): Price and Financial Metrics
WVE Price/Volume Stats
| Current price | $4.66 | 52-week high | $7.67 |
| Prev. close | $4.74 | 52-week low | $3.15 |
| Day low | $4.64 | Volume | 407,000 |
| Day high | $4.81 | Avg. volume | 835,094 |
| 50-day MA | $5.49 | Dividend yield | N/A |
| 200-day MA | $5.06 | Market Cap | 569.84M |
WVE Stock Price Chart Interactive Chart >
Wave Life Sciences Ltd. - Ordinary Shares (WVE) Company Bio
WAVE Life Sciences Pte. Ltd., a preclinical biopharmaceutical company, designs, develops, and commercializes nucleic acid therapeutic candidates. The company was founded in 2012 and is based in Simgapore.
Latest WVE News From Around the Web
Below are the latest news stories about WAVE LIFE SCIENCES LTD that investors may wish to consider to help them evaluate WVE as an investment opportunity.
Wave Life Sciences Announces Initiation of Dosing in Phase 2 FORWARD-53 Trial of WVE-N531 in Duchenne Muscular DystrophyFORWARD-53 is fully enrolled with potentially registrational dystrophin expression data expected in 2024 Previous clinical proof-of-concept data demonstrated highest level of exon skipping ever observed in the clinic and that WVE-N531 was present in myogenic stem cells, which are important for potential muscle regeneration CAMBRIDGE, Mass., Dec. 15, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatme |
Wave Life Sciences Ltd.'s (NASDAQ:WVE) recent 35% pullback adds to one-year year losses, institutional owners may take drastic measuresKey Insights Institutions' substantial holdings in Wave Life Sciences implies that they have significant influence over... |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time to start off Thursday with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning! |
Wave Life Sciences Prices $100 Million Public Offering of Ordinary SharesCAMBRIDGE, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today the pricing of its previously announced underwritten public offering of 20,000,000 of its ordinary shares at a price to the public of $5.00 per ordinary share. Gross proceeds to Wave Life Sciences from the offering are expected to be approximately $100 million, b |
Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded WarrantsCAMBRIDGE, Mass., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that it has commenced an underwritten public offering of $100 million in aggregate of its ordinary shares, and, to certain investors that so choose in lieu of ordinary shares, pre-funded warrants to purchase ordinary shares. In connection with the offering, Wave |
WVE Price Returns
| 1-mo | N/A |
| 3-mo | 4.25% |
| 6-mo | -13.38% |
| 1-year | 16.79% |
| 3-year | -23.98% |
| 5-year | -82.43% |
| YTD | -7.72% |
| 2023 | -27.86% |
| 2022 | 122.93% |
| 2021 | -60.10% |
| 2020 | -1.81% |
| 2019 | -80.93% |
Continue Researching WVE
Want to see what other sources are saying about Wave Life Sciences Ltd's financials and stock price? Try the links below:Wave Life Sciences Ltd (WVE) Stock Price | Nasdaq
Wave Life Sciences Ltd (WVE) Stock Quote, History and News - Yahoo Finance
Wave Life Sciences Ltd (WVE) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...